Private Advisor Group’s AGF US Market Neutral Anti-Beta Fund BTAL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-38,338
Closed -$799K 2492
2025
Q1
$799K Buy
38,338
+18,296
+91% +$347K ﹤0.01% 1353
2024
Q4
$370K Buy
20,042
+89
+0.4% +$1.71K ﹤0.01% 1747
2024
Q3
$391K Sell
19,953
-1,693
-8% -$33.7K ﹤0.01% 1756
2024
Q2
$425K Buy
21,646
+1,037
+5% +$19.7K ﹤0.01% 1653
2024
Q1
$371K Sell
20,609
-73,754
-78% -$1.34M ﹤0.01% 1702
2023
Q4
$1.6M Buy
94,363
+56,855
+152% +$1.13M 0.01% 870
2023
Q3
$745K Buy
37,508
+4,757
+15% +$90.1K 0.01% 1187
2023
Q2
$600K Sell
32,751
-54,675
-63% -$1.1M 0.01% 1288
2023
Q1
$1.78M Buy
87,426
+36,596
+72% +$736K 0.02% 733
2022
Q4
$1.07M Buy
+50,830
New +$1.05M 0.05% 343

Other funds holding BTAL

Private Advisor Group's BTAL Position: Q2 2025 in Review

Private Advisor Group sold out of AGF US Market Neutral Anti-Beta Fund (BTAL) in Q2 2025, closing a stake of 38,338 shares — an estimated $799K sold.

Private Advisor Group first reported a position in BTAL in Q4 2022 and held it in 10 quarters. The position peaked at $1.78M in Q1 2023. 80 funds tracked by Wall St. Rank hold BTAL as of Q2 2025.

  • Private Advisor Group reported no remaining AGF US Market Neutral Anti-Beta Fund position as of Q2 2025 after selling out during the quarter.
  • Private Advisor Group sold 38,338 AGF US Market Neutral Anti-Beta Fund shares in Q2 2025, an estimated $799K.
  • Private Advisor Group first reported a position in AGF US Market Neutral Anti-Beta Fund in Q4 2022 and held it in 10 quarters.
  • Private Advisor Group's AGF US Market Neutral Anti-Beta Fund position peaked at $1.78M in Q1 2023.
  • 80 funds tracked by Wall St. Rank held AGF US Market Neutral Anti-Beta Fund as of Q2 2025.

Based on Private Advisor Group's 13F filing for Q2 2025, filed 11 Aug 2025.